Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M. Tuberculosis Infection
Overview
Authors
Affiliations
Although vitamin D deficiency is a common feature among patients presenting with active tuberculosis, the full scope of vitamin D action during Mycobacterium tuberculosis (Mtb) infection is poorly understood. As macrophages are the primary site of Mtb infection and are sites of vitamin D signaling, we have used these cells to understand the molecular mechanisms underlying modulation of the immune response by the hormonal form of vitamin D, 1,25-dihydroxyvitamin D (1,25D). We found that the virulent Mtb strain H37Rv elicits a broad host transcriptional response. Transcriptome profiling also revealed that the profile of target genes regulated by 1,25D is substantially altered by infection, and that 1,25D generally boosts infection-stimulated cytokine/chemokine responses. We further focused on the role of 1,25D- and infection-induced interleukin 1β (IL-1β) expression in response to infection. 1,25D enhanced IL-1β expression via a direct transcriptional mechanism. Secretion of IL-1β from infected cells required the NLRP3/caspase-1 inflammasome. The impact of IL-1β production was investigated in a novel model wherein infected macrophages were co-cultured with primary human small airway epithelial cells. Co-culture significantly prolonged survival of infected macrophages, and 1,25D/infection-induced IL-1β secretion from macrophages reduced mycobacterial burden by stimulating the anti-mycobacterial capacity of co-cultured lung epithelial cells. These effects were independent of 1,25D-stimulated autophagy in macrophages but dependent upon epithelial IL1R1 signaling and IL-1β-driven epithelial production of the antimicrobial peptide DEFB4/HBD2. These data provide evidence that the anti-microbial actions of vitamin D extend beyond the macrophage by modulating paracrine signaling, reinforcing its role in innate immune regulation in humans.
Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial Fibrillation.
Zheng E, Warchol I, Mejza M, Mozdzan M, Strzeminska M, Bajer A J Clin Med. 2025; 14(3).
PMID: 39941553 PMC: 11818443. DOI: 10.3390/jcm14030882.
Buendia J, Patino D Cost Eff Resour Alloc. 2024; 22(1):83.
PMID: 39543659 PMC: 11566492. DOI: 10.1186/s12962-024-00589-2.
Topical Vitamin D Prevents Bone Loss and Inflammation in a Mouse Model.
Kirkwood K, Van Dyke T, Kirkwood C, Zhang L, Panezai J, Duran-Pinedo A J Dent Res. 2024; 103(9):908-915.
PMID: 39104028 PMC: 11465324. DOI: 10.1177/00220345241259417.
In vivo vitamin D target genes interconnect key signaling pathways of innate immunity.
Jaroslawska J, Ghosh Dastidar R, Carlberg C PLoS One. 2024; 19(7):e0306426.
PMID: 39042613 PMC: 11265685. DOI: 10.1371/journal.pone.0306426.
Arnett E, Wolff J, Leopold Wager C, Simper J, Badrak J, Ontiveros C J Immunol. 2024; 212(5):765-770.
PMID: 38251918 PMC: 10922714. DOI: 10.4049/jimmunol.2300418.